MPH Health Care AG is a listed investment company with a strategic focus on investments in the growth segments of the healthcare market around chronic diseases, medical aesthetic treatments and digitalisation in the healthcare sector. In addition, MPH specifically exploits potential in other high-growth and high-profit sectors. It invests for the long term and allows its shareholders to participate in the development of its holdings through an attractive dividend policy.

Stock

ISIN: DE000A289V03 | WKN: A289V0 | Stock exchange symbol: 93M1

Title name: Bearer Shares
Number of shares: 4,281,384
Designated Sponsor: ODDO SEYDLER BANK AG
First trading day: 01.09.2009

Share information

Downloads

You can find our current annual and interim reports here: Reports

| Investor News

  • Proposed dividend of EUR 5.00 per share (previous year: EUR 1.20), to be approved at the Annual General Meeting on 9 July 2026
  • Net loss for the period of EUR 52.0 million (same quarter last year: EUR 20.0 million), primarily due to the non-cash fair value measurement of the investment in M1 Kliniken AG
  • Equity ratio remains very high: 91.9% (previous year, 31 December 2025: 94.3%)
  • M1 Kliniken AG’s beauty division reports a strong first quarter of 2026: revenue up 5.7% to EUR 27.1 million, EBIT up 37.6% to EUR 9.2 million, EBIT margin at 33.9% (same quarter last year: 26.0%)    

| Investor News

  • Equity ratio remains very high: 94.3% (previous year: 95.5%)
  • Net loss for the year of €29.3 million, primarily due to a non-cash one-off item arising from the fair value measurement of the CR Energy investment
  • Key holding M1 Kliniken AG reports strong financial year 2025: EBIT up 29%,
    „Beauty“ segment exceeds €100 million in revenue for the first time
  • Increased dividend of €5.00 per share proposed (previous year: €1.20)

| Investor News

At today's balance sheet meeting, the Supervisory Board of MPH Health Care AG (ISIN: DE000A289V03) approved the annual financial statements and the consolidated financial statements of the Company for the 2025 financial year, as submitted by the Management Board, in accordance with §§ 171, 172 AktG. The annual financial statements are thereby adopted pursuant to § 172 AktG.

The Supervisory Board and the Management Board today resolved to propose to the Annual General Meeting a dividend of EUR 5.00 per dividend-bearing share.

The 2025 Annual Report of MPH Health Care AG is expected to be published on 27 May 2026.

Contact

MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Deutschland

T. +49 (0) 30 863 21 45 – 60

To the contact form